Literature DB >> 16415657

Postprandial lipemia in postmenopausal women with high fasting high-density lipoprotein cholesterol.

Genovefà D Kolovou1, Katherine K Anagnostopoulou, Klelia D Salpea, Nektarios D Pilatis, Stella Iraklianou, Georgia Grapsa, Alexandros Pantelakis, Konstantinos Tsarpalis, Evaggelia Kapnia, Dennis V Cokkinos.   

Abstract

BACKGROUND: Several groups of patients at high risk for cardiovascular disease have been found to show an exaggerated postprandial hypertriglyceridemia. Postprandial lipemia (PPL) therefore has been implicated as a potential additional risk factor that has been evading us. The purpose of this study was to test the effect of high fasting high-density lipoprotein cholesterol (HDL-C) levels on PPL in postmenopausal females.
METHODS: Oral fat tolerance test, as quantified by the areas under the curve (AUC) of triglyceride (TG) levels, was given to 3 groups: normal postmenopausal females (control), postmenopausal females with exceptionally high HDL-C and a familial history of longevity (longevity syndrome), and postmenopausal females that were heterozygotes of familial hypercholesterolemia (hFH) with exceptionally high HDL-C.
RESULTS: The PPL was not different between the control and longevity syndrome groups but was significantly higher in the hFH group; AUC (SD), in mg/dl/h; 749 (195), 882 (278) and 1244 (497) respectively, p=0.002. In linear regression analysis only fasting TG levels were a significant predictor of the AUC (Coefficient B = 11.779, p < 0.001).
CONCLUSIONS: In subjects with longevity syndrome the PPL is similar to controls, which means that high fasting HDL-C has not any beneficial influence on PPL. The fasting TG concentration is the main determinant of PPL. Furthermore, postmenopausal females with hFH have higher TG response postprandially, even in the case of high fasting HDL-C. Whether there is a threshold below or above, where HDL-C becomes a significant independent determinant of PPL is a question to be answered by future research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415657     DOI: 10.1097/00000441-200601000-00005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

Review 1.  Dyslipidemia and cardiovascular disease in women.

Authors:  Renata Cífková; Alena Krajčoviechová
Journal:  Curr Cardiol Rep       Date:  2015-07       Impact factor: 2.931

2.  Cholesteryl ester transfer protein gene polymorphisms and longevity syndrome.

Authors:  Genovefa Kolovou; Marianna Stamatelatou; Katherine Anagnostopoulou; Peggy Kostakou; Vana Kolovou; Constantinos Mihas; Ioannis Vasiliadis; Olga Diakoumakou; Dimitri P Mikhailidis; Dennis V Cokkinos
Journal:  Open Cardiovasc Med J       Date:  2010-01-29

3.  One more look at guidelines for primary and secondary prevention of cardiovascular disease in women.

Authors:  Genovefa Kolovou; Apostolia Marvaki; Helen Bilianou
Journal:  Arch Med Sci       Date:  2011-11-08       Impact factor: 3.318

4.  Narrowing sex differences in lipoprotein cholesterol subclasses following mid-life: the very large database of lipids (VLDL-10B).

Authors:  Kristopher J Swiger; Seth S Martin; Michael J Blaha; Peter P Toth; Khurram Nasir; Erin D Michos; Gary Gerstenblith; Roger S Blumenthal; Steven R Jones
Journal:  J Am Heart Assoc       Date:  2014-04-22       Impact factor: 5.501

5.  Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia.

Authors:  Katherine K Anagnostopoulou; Genovefa D Kolovou; Peggy M Kostakou; Constantinos Mihas; Georgios Hatzigeorgiou; Christina Marvaki; Dimitrios Degiannis; Dimitri P Mikhailidis; Dennis V Cokkinos
Journal:  Lipids Health Dis       Date:  2009-06-26       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.